Biology subjects

Wolf, S. A.

Publications and source records attributed to Wolf, S. A..

5 recordsLinked to original sources

bioRxiv2026

Bridging disciplines towards wastewater-based surveillance of antimicrobial resistance: frequency, local dynamics, and genomic characteristics of carbapenemase-producing Klebsiella pneumoniae

The World Health Organization (WHO) has designated carbapenemase-producing Klebsiella pneumoniae (CP-KP) as a critical priority pathogen due to its increasing importance for human health. As wastewater-based surveillance (WBS) is discussed as a complementary tool for classical systems regarding hazard forecasting and early-warning, we designed a "wet-lab to genomics" workflow to target CP-KP in raw influent wastewater samples to support method development processes across different scientific disciplines. The CP-KP screening workflow was set up based on membrane filtration, selective chromogenic media for selective cultivation and the modified carbapenem inactivation method (mCIM) for confirming carbapenemase-production using 33 samples from four different wastewater treatment plants in North-Eastern Germany. All samples tested positive for CP-KP, with concentrations ranging between 102 and 104 colony-forming units (cfu) per 100 ml across the sample set. As a result, 320 isolates belonged to the Klebsiella, Enterobacter, Citrobacter (KEC)- group, with the majority being identified as KP (n= 297; 93%), including n= 253 (79%) verified CP-KP. Genotypic characterization of CP-KP by PCR revealed the predominance of blaOXA-48-related genes (n= 83) among isolates from all WWTPs. As quality parameters, colony counts for viable Escherichia coli (EC) were employed as a proxy for valid wastewater samples and extended-spectrum beta-lactamase-producing E. coli (ESBL-EC) as indicator for AMR, with cfu/100 ml ranges from 10 to 10 and 102 to 10, respectively. To verify the screening outcome, a subset of 58 CP-KP from two WWTPs were subjected to whole genome sequencing (WGS). As a result, eight different sequence types (STs), i.e., ST147 and ST273 (both: clonal group 147), ST258, ST35, ST15, ST37, ST307, and ST485 were identified. These include clinically relevant STs clustering closest with fecal isolates from Germany when compared with Pathogenwatch-database entries. Moreover, WGS data enabled the identification of antibiotic resistance genes (ARGs), and the detection of closely related isolates within the WWTP dataset.

microbiology↗

bioRxiv2025

Discovery of a new fibronectin-binding surface protein of Streptococcus canis with serum opacification activity through Transposon Directed Insertion-Site Sequencing

Infective endocarditis is a rare but severe disease in humans and dogs which can be caused by Streptococcus canis. The bacterial factors that mediate endothelial adherence remain poorly defined. To understand how S. canis can adhere to and invade the endocardium, we combined a high-throughput approach called transposon directed insertion-site sequencing (TraDIS) with a physiologically relevant endothelial infection model that incorporates venous-range shear stress to identify S. canis genes required for host cell interaction. A saturated transposon library of clinical strain IMT49926 was screened in a microfluidic infection assay, enabling genome-wide selection of mutants impaired in endothelial adhesion. Comparative analysis of input and non-adherent output pools revealed several candidate genes, including a fibronectin-binding LPXTG-anchored surface protein with high homology to streptococcal serum opacity factors (SOFs). Our findings identified ScSOF as a multifunctional surface protein that plays an important role in the infection potential of S. canis. It facilitates adhesion to endothelial cells, prevents endothelial wound closure, contributes to the streptococcal surface architecture, binds fibronectin, opacifies serum, and inhibits {beta}-haemolytic activity. ScSOF represents a strong candidate for future studies into pathogenesis, immune evasion, and (potentially) vaccine or therapeutic targeting in S. canis infections. Authors summaryStreptococcus canis is a bacterium commonly found in healthy dogs and cats, but it can sometimes cause serious infections in animals and humans, including infective endocarditis, a dangerous infection of the heart lining. To cause this disease, the bacteria must first attach to and invade the cells that line blood vessels. However, very little is known about how S. canis can do this. In this study, we used a genetic screening method that includes all the genes from S. canis to identify which bacterial genes are needed for attachment to human endothelial cells under conditions that mimic real blood flow. We discovered a previously uncharacterized surface protein, which we named ScSOF, that plays several important roles during infection. ScSOF helps the bacteria bind to fibronectin, a major host tissue protein, alters the bacterial surface structure, and causes serum opacification, a known marker of virulence in related streptococci. When ScSOF was removed, the bacteria were much less able to attach to endothelial cells, cause cell damage, or interfere with the healing of endothelial wounds. Our findings show that ScSOF is a key factor that enables S. canis to interact with host tissues and may contribute to heart valve infections.

microbiology↗

bioRxiv2023

Microglia undergo transcriptional, translational and functional adaptations to dark and light phases in laboratory mice

Microglia cells are increasingly recognized to contribute to brain health and disease. Preclinical studies using laboratory rodents are essential to advance our understanding of the physiological and pathophysiological functions of these cells in the central nervous system. Rodents are nocturnal animals, and they are mostly maintained in a defined light-dark cycle within animal facilities, with many laboratories investigating microglial molecular and functional profiles during the animals light (sleep) phase. However, only a few studies have considered possible differences in microglial functions between the active and sleep phases. Based on initial evidence suggesting that microglial intrinsic clock genes can affect their phenotype, we sought to investigate differences in transcriptional, proteotype and functional profiles of microglia between light (sleep) and dark (active) phases, and how these changes are affected in pathological models. We found marked transcriptional and proteotype differences between microglia harvested during the light or dark phase. Amongst others, these differences related to genes and proteins associated with immune responses, motility, and phagocytosis, which were reflected by functional alterations in microglial synaptic pruning and response to bacterial stimuli. Possibly accounting for such circadian changes, we found RNA and protein regulation in SWI/SNF and NuRD chromatin remodeling complexes between light and dark phases. Importantly, we show that microglial circadian transcriptional changes are impaired in a model of immune-mediated neurodevelopmental disorders. Our findings emphasize the importance of considering circadian factors in studying microglial cells and indicate that implementing a circadian perspective is pivotal for advancing our understanding of their physiological and pathophysiological roles in brain health and disease. This may also open novel avenues towards therapeutic strategies for modulating microglial functions during specific windows of the active or sleep phase.

neuroscience↗

bioRxiv2023

Antibiotic prophylaxis and hospitalization of horses subjected to median laparotomy: gut microbiota trajectories and abundance increase of Escherichia

Horse clinics are hotspots for the accumulation and spread of clinically relevant and zoonotic multidrug-resistant bacteria, including extended-spectrum {beta}-lactamase producing (ESBL) Enterobacterales. Although median laparotomy in cases of acute equine colic is a frequently performed surgical intervention, knowledge about the effects of peri-operative antibiotic prophylaxis (PAP) based on a combination of penicillin and gentamicin on the gut microbiota is limited. Therefore, we collected fecal samples of horses from a non-hospitalized control group (CG) and from horses receiving either a pre-surgical single-shot (SSG) or a peri-operative 5-day (5DG) course of PAP. To assess differences between the two PAP regimens and the CG, all samples obtained at hospital admission (t0), on days three (t1) and ten (t2) after surgery, were screened for ESBL-producing Enterobacterales and subjected to 16S rRNA V1- V2 gene sequencing. We included 48 samples in the SSG (n=16 horses), 45 in the 5DG (n=15) and 20 in the CG (n=10). Two samples (6.5%) were positive for ESBL-producing Enterobacterales at t0 while this rate increased to 67% at t1 and decreased only slightly at t2 (61%). Shannon diversity index (SDI) was used to evaluate alpha-diversity changes, revealing that horses suffering from acute colic seemed to have a compromised fecal microbiota composition (5DG, SDImean of 5.90; SSG, SDImean of 6.17) when compared to the CG (SDImean of 6.53) at t0, although the difference lacked significance. Alpha-diversity decreased significantly in both PAP groups at t1, while at t2 the onset of microbiome recovery was noticed. Although we did not identify a significant SDImean difference with respect to PAP duration, the community structure (beta-diversity) was considerably restricted in samples of the 5DG at t1, most likely due to the ongoing administration of antibiotics. An increased abundance of Enterobacteriaceae, especially Escherichia, was noted for both study groups at t1. Further studies are needed to reveal important factors promoting the increase and residency of ESBL-producing Enterobacterales among hospitalized horses.

microbiology↗

bioRxiv2022

Gene amplifications cause high-level resistance against albicidin in Gram-negative bacteria

Antibiotic resistance is a continuously increasing concern for public health care. Understanding resistance mechanisms and their emergence is crucial for the development of new antibiotics and their effective use. Here, we report the discovery of a gene amplification-based mechanism that imparts an up to 1000-fold increase in resistance levels against the antibiotic albicidin. We show that this mechanism protects Salmonella Typhimurium and Escherichia coli by increasing the copy number of the GyrI-like transcription regulator STM3175 (YgiV) which binds albicidin. X-ray crystallography and molecular docking studies reveal a conserved binding motif that can interact with aromatic building blocks of albicidin. Phylogenetic studies suggest that this resistance mechanism is ubiquitous in Gram-negative bacteria and our experiments confirm that STM3175 homologs can convey resistance in pathogens such as Vibrio vulnificus and Pseudomonas aeruginosa.

microbiology↗